DrugsControl Media Services
DrugsControl.org

News Detail

AbbVie Healthcare India rejects allegations of the DoP (25-12-2024)

New Delhi, 25 Dec 2024: AbbVie Healthcare India which has been in the dock for unethical marketing practices today rejected the allegations of wrongdoing by the Department of Pharmaceuticals (DoP).

Calling the DoP’s action “without merit” it said that......
View Details

Source : Economic Times
AbbVie Healthcare India Department of Pharmaceuticals unethical marketing practices Allergan Aesthetics healthcare professionals

Related News